| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |